Quick Definition
What is Low Endotoxin FBS?: Low endotoxin FBS is fetal bovine serum that has been processed and tested to contain less than 1 EU/mL (endotoxin unit per millilitre) of lipopolysaccharide (LPS). Standard FBS typically contains 1–10 EU/mL endotoxin, which is sufficient to activate TLR4-mediated immune signalling in sensitive cell types.
Why does endotoxin in FBS matter?
Endotoxin (lipopolysaccharide, LPS) is a highly potent immune activator. At concentrations as low as 0.1 EU/mL, LPS activates TLR4 signalling in sensitive cell types — triggering NF-κB nuclear translocation and transcription of pro-inflammatory genes. In standard FBS at 10%, cells in culture are continuously exposed to LPS at concentrations (0.1–1 EU/mL in the medium) that chronically activate these pathways.
When is low endotoxin FBS required?
- Drug screening targeting NF-κB, inflammatory pathways, or innate immunity: endotoxin background inflates apparent IC50
- AAV viral vector production in HEK293T: endotoxin reduces transfection efficiency and vector yield
- Cytokine ELISA and multiplex assays: endotoxin creates non-specific background cytokine signal
- Hepatocyte-based CYP induction assays: endotoxin suppresses baseline CYP3A4 expression
- iPSC differentiation with cytokine-driven protocols: endotoxin competes with defined growth factor signalling
Key Facts
- Endotoxin (LPS) is a component of gram-negative bacterial cell walls — present in standard FBS as a processing contaminant
- Standard FBS endotoxin: 1–10 EU/mL. Low endotoxin FBS: <1 EU/mL (tested by LAL chromogenic assay)
- LPS activates TLR4 → NF-κB → pro-inflammatory cytokine expression (IL-6, TNF-α, IL-1β) in monocytes, macrophages, hepatocytes and many other cell types
- In drug screening, endotoxin-driven NF-κB activation can increase apparent IC50 values by 3–10× for compounds targeting inflammatory pathways
- In AAV production (HEK293T), endotoxin activates antiviral interferon pathways that reduce transfection efficiency and AAV yield
- In cytokine multiplex assays, endotoxin creates non-specific cytokine background that masks treatment effects
- SeamlessBio FBS Low Endotoxin is tested to <1 EU/mL by LAL chromogenic assay on every lot
Further Reading
- What is FBS?
- AAV Viral Vector Production — FBS Guide
- Cytotoxicity Assays — FBS Selection Guide
- In Vitro Drug Metabolism — Matrix Guide
FBS Low Endotoxin (<1 EU/mL) — Available from SeamlessBio
Request a free sample or quote within 48 hours.
View Product → Muster anfordernSeamlessBio GmbH · Passau, Germany · info@seamlessbio.de · +49 851 37932226
